Stability of time trade-off utilities for health states associated with the treatment of prostate cancer
- PMID: 12113388
- DOI: 10.1023/a:1015609126536
Stability of time trade-off utilities for health states associated with the treatment of prostate cancer
Abstract
Background: Patients diagnosed with localized prostate cancer face several treatment options. Patient preferences for treatment side effects often dominate the decision making process. We proposed to learn more about the nature of patient preferences, or utilities, for these side effects.
Methods: Two hundred and fifteen men were consecutively enrolled from three institutions for assessment after prostate needle biopsy. Baseline and 6 month follow-up assessments were done using the University of California, Los Angeles Prostate Cancer Index (UCLA PCI), and a laptop utility assessment application, U-Titer II. Patient utility was assessed for current pelvic functions as well as hypothetical pelvic dysfunctions. We calculated stability of utility scores and correlations between utility scores and UCLA PCI scores.
Results: Utility scores for current pelvic functions exhibited a significant 'ceiling effect.' Utility scores for current pelvic functions and hypothetical impaired states were stable after 6 months in patients with negative biopsies. In patients who underwent treatment, utility for current sexual function decreased by 0.13 units (p < 0.00) and utility for current urinary function decreased by 0.09 units (p < 0.01). Utility for hypothetical stress urinary incontinence rose in men with a >25-point drop in UCLA PCI score.
Conclusion: Utilities for some 'current' pelvic functions decreased in tandem with UCLA PCI scores in men who experienced >25-point changes in these scores. Utilities for some 'hypothetical' pelvic dysfunctions rose as men began to actually experience functional changes in those areas.
Similar articles
-
Patient and community preferences for outcomes in prostate cancer: implications for clinical policy.Med Care. 2003 Jan;41(1):153-64. doi: 10.1097/00005650-200301000-00017. Med Care. 2003. PMID: 12544552
-
Responsiveness of the University of California-Los Angeles Prostate Cancer Index.Urology. 2010 Jun;75(6):1418-23. doi: 10.1016/j.urology.2009.04.070. Epub 2009 Jul 8. Urology. 2010. PMID: 19589573
-
Analysis linking UCLA PCI with Expanded Prostate Cancer Index Composite: an evaluation of health related quality of life in Japanese men with localized prostate cancer.J Urol. 2007 Aug;178(2):473-7; discussion 477. doi: 10.1016/j.juro.2007.03.113. Epub 2007 Jun 11. J Urol. 2007. PMID: 17561164
-
The effect of androgen deprivation therapy on health-related quality of life in men with prostate cancer.Urology. 2001 Aug;58(2 Suppl 1):94-100. doi: 10.1016/s0090-4295(01)01250-x. Urology. 2001. PMID: 11502459 Review.
-
A review of measurement of patient preferences for treatment outcomes after prostate cancer.Urology. 2002 Sep;60(3 Suppl 1):72-7; discussion 77-8. doi: 10.1016/s0090-4295(02)01577-7. Urology. 2002. PMID: 12231054 Review.
Cited by
-
The stability of utility scores: test-retest reliability and the interpretation of utility scores in elective total hip arthroplasty.Qual Life Res. 2004 Feb;13(1):15-22. doi: 10.1023/B:QURE.0000015307.33811.2d. Qual Life Res. 2004. PMID: 15058783
-
Use of forecasted assessment of quality of life to validate time-trade-off utilities and a prostate cancer screening decision-analytic model.Health Expect. 2015 Oct;18(5):1610-20. doi: 10.1111/hex.12150. Epub 2013 Oct 23. Health Expect. 2015. PMID: 26039695 Free PMC article.
-
Eliciting utilities using functional methodology: people's disutilities for the adverse outcomes of cardiopulmonary resuscitation.Qual Life Res. 2006 Apr;15(3):429-39. doi: 10.1007/s11136-005-2830-y. Qual Life Res. 2006. PMID: 16547782
-
Association between utility and treatment among patients with prostate cancer.Qual Life Res. 2010 Jun;19(5):711-20. doi: 10.1007/s11136-010-9622-8. Epub 2010 Mar 5. Qual Life Res. 2010. PMID: 20204704
-
Health Utility Book (HUB)-Cancer: Protocol for a Systematic Literature Review of Health State Utility Values in Cancer.MDM Policy Pract. 2019 Aug 13;4(2):2381468319852594. doi: 10.1177/2381468319852594. eCollection 2019 Jul-Dec. MDM Policy Pract. 2019. PMID: 31453359 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous